Earnings Call · Q1 FY2024·2024-05-02

Q1 24EPS +13.69%·Rev n/aQ4 23EPS -4.88%·Rev n/aQ3 23EPS 0.00%·Rev n/aQ2 23EPS -0.67%·Rev n/a⚠ consensus missing

AGIOS PHARMACEUTICALS, INC. AGIO

Chris Taylor — Vice President, Investor Relations and Corporate Communications

Brian Goff — President and Chief Executive Officer

Sarah Gheuens — Senior Vice President, Clinical Development

Tsveta Milanova — Chief Commercial Officer

Cecilia Jones — Chief Financial Officer

+2.7%1d on move date+1.8% vs SPY3d−1.3%5d−3.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AGIO calls or request research access.

More AGIO calls Browse calls Request research access